Penny Heaton
CIK 1409296 · View on SEC EDGAR ↗
First SEC filing: Aug. 13, 2007 · Latest: Aug. 13, 2007
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 2, 2009 | NVAX | S | 8,333 | $2.86 | $23,832 | 18,667 Direct | -30.86% | Disposed | -85.4% (price as of 2026-08-20) |
| July 31, 2008 | NVAX | P | 880 | — | — | 880 Direct | — | Acquired | (price as of 2026-08-20) |
| July 31, 2008 | NVAX | P | 1,759 | — | — | 28,159 Direct | +6.66% | Acquired | (price as of 2026-08-20) |
| Jan. 30, 2008 | NVAX | P | 1,100 | $3.05 | $3,355 | 26,100 Direct | +4.40% | Acquired | -86.3% (price as of 2026-08-20) |
| Jan. 30, 2008 | NVAX | P | 900 | $3.05 | $2,745 | 27,000 Direct | +3.45% | Acquired | -86.3% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 5, 2009 | NVAX | Option Right to Buy | Common Stock (75,000) | $0.56 | March 5, 2019 | 75,000 | Acquired |
| July 31, 2008 | NVAX | Warrant - right to buy | Common Stock (880) | $3.62 | July 31, 2013 | 880 | Acquired |
| March 6, 2008 | NVAX | Option - right to buy | Common Stock (75,000) | $2.61 | March 6, 2018 | 75,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
NVAX
M.D.(11) Former VP & Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2009 | $261,643 | — | — | $29,288 | — | — | $39,141 | $330,072 |
| 2008 | $285,405 | — | — | $112,642 | — | — | $18,281 | $416,328 |
| 2007 | $261,704 | — | — | $82,412 | $99,087 | — | $44,115 | $487,318 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.